Lisa Campbell put off getting her mammogram only to find out she had a "fast moving" variation of Breast Cancer. Now she she is urging other women not to delay.
Delta surge in South raises fears of winter outbreaks in North washingtonexaminer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonexaminer.com Daily Mail and Mail on Sunday newspapers.
Jul 16, 2021
THURSDAY, July 15, 2021 (HealthDay News) Pandemic-related disruptions in breast cancer care experienced during the first six months of the pandemic are expected to have a long-term cumulative impact on breast cancer mortality in the United States, according to a study published online July 14 in the
Journal of the National Cancer Institute.
Oguzhan Alagoz, Ph.D., from the University of Wisconsin-Madison, and colleagues projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy among women with early-stage disease during the first six months of the pandemic were modeled as was the return to prepandemic patterns.
A new paper in the
Journal of the National Cancer Institute, published by Oxford University Press, indicates that disruptions in health care due to the COVID 19 pandemic may increase breast cancer deaths.
In March 2020 public health measures prohibited most elective procedures, including mammography, due to hospital capacity and limited personal protective equipment. This reduced mammograms up to 80%. Breast cancer patients also experienced treatment delays and reductions in planned or expected chemotherapy treatments.
Researchers here used three independently-developed breast cancer simulation models from the National Cancer Institute s Cancer Intervention and Surveillance Modeling Network to predict the effect of COVID-19-related interruptions on breast cancer mortality due to health care delivery disruptions in the first 6 months of the pandemic.
COVID-19 pandemic could lead to nearly 2,500 excess deaths from breast cancer by 2030 due to women missing screenings, diagnoses and treatments
Disruptions during early months of the pandemic delayed breast cancer screenings and treatments - leading to increased deaths in the coming years
About 2,500 more Americans may die from breast cancer before 2030 because of COVID-19 delays, a study from the University of Wisconsin estimates
If screenings and treatments were delayed by a year instead of six months, that number could rise to 5,000
Healthcare facilities should screen women who missed their mammograms during the pandemic, researchers say